Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension.

Autor: Moon JS; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea., Park IR; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea., Kim HJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea., Chung CH; Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea., Won KC; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea., Han KA; Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea., Park CY; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea., Won JC; Department of Internal Medicine, Inje University Sanggye Paik Hospital, Seoul, Korea., Kim DJ; Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea., Koh GP; Department of Internal Medicine, Jeju National University College of Medicine, Jeju, Korea., Kim ES; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea., Yu JM; Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea., Hong EG; Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea., Lee CB; Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea., Yoon KH; Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Publikováno v: Diabetes & metabolism journal [Diabetes Metab J] 2023 Nov; Vol. 47 (6), pp. 808-817. Date of Electronic Publication: 2023 Sep 26.

Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise.

Autor: Park J; Department of Endocrinology and Metabolism, Division of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea., Park SW; Department of Endocrinology and Metabolism, Division of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea., Yoon KH; Department of Endocrinology and Metabolism, Division of Internal Medicine, Seoul St Mary's Hospital, Catholic University of Korea, Seoul, Korea., Kim SR; Department of Endocrinology and Metabolism, Division of Internal Medicine, Bucheon St. Mary's Hospital, Catholic University of Korea, Bucheon, Korea., Ahn KJ; Department of Endocrinology and Metabolism, Division of Internal Medicine, Kangdong Kyung Hee Hospital, Kyung Hee University School of Medicine, Seoul, Korea., Lee JH; Department of Endocrinology and Metabolism, Division of Internal Medicine, Myongji Hospital, Kwandong University College of Medicine, Koyang, Korea., Mok JO; Department of Endocrinology and Metabolism, Division of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea., Chung CH; Department of Endocrinology and Metabolism, Division of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea., Han KA; Department of Endocrinology and Metabolism, Division of Internal Medicine, Eulji University School of Medicine, Daejeon, Korea., Koh GP; Department of Endocrinology and Metabolism, Division of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea., Kang JG; Department of Endocrinology and Metabolism, Division of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea., Lee CB; Department of Endocrinology and Metabolism, Division of Internal Medicine, Hanyang University Guri Hospital, Hanyang University Medical School, Guri, Korea., Kim SH; Department of Cardiology, Division of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea., Kwon NY; Division of Biostatistics, Clinical Development Team, Dong-A ST Co., LTD., Seoul, Korea., Kim DM; Department of Endocrinology and Metabolism, Division of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2017 Dec; Vol. 19 (12), pp. 1681-1687. Date of Electronic Publication: 2017 Jul 07.

Response: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:41-9).

Autor: Kim ST; Department of Internal Medicine, Konyang University Hospital, Konyang University School of Medicine, Daejon, Korea., Kim BJ, Lim DM, Song IG, Jung JH, Lee KW, Park KY, Cho YZ, Lee DH, Koh GP

Publikováno v: Diabetes & metabolism journal [Diabetes Metab J] 2011 Apr; Vol. 35 (2), pp. 190-1. Date of Electronic Publication: 2011 Apr 30.

Detection of replicating negative-sense RNAs in CaCo-2 cells infected with human astrovirus.

Autor: Jang SY; Department of Microbiology, College of Natural Sciences, Chungbuk National University, Cheongju, Chungbuk, South Korea., Jeong WH, Kim MS, Lee YM, Lee JI, Lee GC, Paik SY, Koh GP, Kim JM, Lee CH

Publikováno v: Archives of virology [Arch Virol] 2010 Sep; Vol. 155 (9), pp. 1383-9. Date of Electronic Publication: 2010 Jun 11.